RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
All Other Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for Denileukin Diftitox:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- WITH THERAPEUTIC USE
- Acute hypersensitivity reaction has been observed within the first 24 hours of infusion. Vascular leak syndrome has also been characterized by hypotension, edema and hypoalbuminemia during clinical trials and is often self-limited requiring minimal treatment. Flu-like syndrome has been reported several days after infusion and can include the following symptoms: fever and/or chills, asthenia, gastrointestinal effects, myalgia and arthralgia. Symptoms are generally mild to moderate. Other effects include: tachycardia, chest pain, thrombotic disorder, hypertension, hypotension, dysrhythmias, edema, pruritus, rash, sweating, hypocalcemia, hypokalemia, nausea, vomiting, diarrhea, anorexia, constipation, dyspepsia, dysphagia, proteinuria, pyuria, elevated serum creatinine, lymphocytopenia, anemia, thrombocytopenia, leukopenia, reversible transaminase elevations, hypoalbuminemia, weight loss, myalgia, arthralgia, dizziness, asthenia, paresthesia, nervousness, confusion, headache, dyspnea, cough, pharyngitis, rhinitis, fever, chills, infection, and injection site reaction.
- INFREQUENT: Pancreatitis, acute renal insufficiency, microscopic hematuria, oral ulcer, hyperthyroidism, and visual changes have been reported infrequently with use.
- WITH POISONING/EXPOSURE
- Clinical events in overdose are anticipated to be an extension of adverse effects. Nausea, vomiting, fever, chills, persistent asthenia were dose- limiting toxicities in patients receiving 31 mcg/kg/day.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.